Synthetic biodegradable polyesters for implantable controlled-release devices
- PMID: 36197839
- DOI: 10.1080/17425247.2022.2131768
Synthetic biodegradable polyesters for implantable controlled-release devices
Abstract
Introduction: Implantable devices can be designed to release drugs to localized regions of tissue at sustained and reliable rates. Advances in polymer engineering have led to the design and development of drug-loaded implants with predictable, desirable release profiles. Biodegradable polyesters exhibit chemical, physical, and biological properties suitable for developing implants for pain management, cancer therapy, contraception, antiviral therapy, and other applications.
Areas covered: This article reviews the use of biodegradable polyesters for drug-loaded implants by discussing the properties of commonly used polymers, techniques for implant formulation and manufacturing, mechanisms of drug release, and clinical applications of implants as drug delivery devices.
Expert opinion: Drug delivery implants are unique systems for safe and sustained drug release, providing high bioavailability and low toxicity. Depending on the implant design and tissue site of deployment, implants can offer either localized or systemic drug release. Due to the long history of use of degradable polyesters in medical devices, polyester-based implants represent an important class of controlled release technologies. Further, polyester-based implants are the largest category of drug delivery implants to reach the point of testing in humans or approval for human use.
Keywords: Polyester; biodegradable implants; controlled release; polymeric implants.
Similar articles
-
Preparation of dexamethasone ophthalmic implants: a comparative study of in vitro release profiles.Pharm Dev Technol. 2018 Mar;23(3):218-224. doi: 10.1080/10837450.2017.1306560. Epub 2017 Mar 30. Pharm Dev Technol. 2018. PMID: 28300463
-
Development of biodegradable polyesters with various microstructures for highly controlled release of epirubicin and cyclophosphamide.Eur J Pharm Sci. 2017 Jan 1;96:440-448. doi: 10.1016/j.ejps.2016.10.014. Epub 2016 Oct 11. Eur J Pharm Sci. 2017. PMID: 27742595
-
Recent Advances in Polymeric Implants.AAPS PharmSciTech. 2019 Sep 3;20(7):300. doi: 10.1208/s12249-019-1510-0. AAPS PharmSciTech. 2019. PMID: 31482251 Review.
-
Biodegradable synthetic polyesters in the technology of controlled dosage forms of antihypertensive drugs - the overview.Expert Opin Drug Deliv. 2019 Sep;16(9):953-967. doi: 10.1080/17425247.2019.1651716. Epub 2019 Aug 12. Expert Opin Drug Deliv. 2019. PMID: 31369295 Review.
-
Controlled release kinetics of p-aminosalicylic acid from biodegradable crosslinked polyesters for enhanced anti-mycobacterial activity.Acta Biomater. 2016 Jan;30:168-176. doi: 10.1016/j.actbio.2015.11.032. Epub 2015 Nov 17. Acta Biomater. 2016. PMID: 26596566
Cited by
-
Mitigating the environmental effects of healthcare: the role of the endocrinologist.Nat Rev Endocrinol. 2025 Jun;21(6):344-359. doi: 10.1038/s41574-025-01098-9. Epub 2025 Mar 13. Nat Rev Endocrinol. 2025. PMID: 40082727 Review.
-
Process Development for Fabricating 3D-Printed Polycaprolactone-Infiltrated Hydroxyapatite Bone Graft Granules: Effects of Infiltrated Solution Concentration and Agitating Liquid.Biomedicines. 2024 Sep 23;12(9):2161. doi: 10.3390/biomedicines12092161. Biomedicines. 2024. PMID: 39335674 Free PMC article.
-
Recent Advances in the Titanium-Based Catalysts for Ring-Opening Polymerization.ACS Omega. 2024 Jul 5;9(28):29983-29993. doi: 10.1021/acsomega.4c00048. eCollection 2024 Jul 16. ACS Omega. 2024. PMID: 39035956 Free PMC article. Review.
-
Recent Developments in Zn-Based Biodegradable Materials for Biomedical Applications.J Funct Biomater. 2022 Dec 20;14(1):1. doi: 10.3390/jfb14010001. J Funct Biomater. 2022. PMID: 36662048 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources